HPC
ZBH icon

HM Payson & Co’s Zimmer Biomet ZBH Stock Holding History

HM Payson & Co’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$402K Hold
4,669
– – 0.01% 329
2026
Q1 		$422K Hold
4,669
– – 0.01% 318
2025
Q4 		$420K Sell
4,669
-992
-18% -$94.1K 0.01% 314
2025
Q3 		$558K Sell
5,661
-400
-7% -$39.6K 0.01% 278
2025
Q2 		$553K Sell
6,061
-774
-11% -$74.8K 0.01% 275
2025
Q1 		$774K Buy
6,835
+212
+3% +$22.7K 0.01% 234
2024
Q4 		$700K Sell
6,623
-50
-0.7% -$5.37K 0.01% 246
2024
Q3 		$720K Sell
6,673
-50
-0.7% -$5.46K 0.01% 250
2024
Q2 		$730K Sell
6,723
-102
-1% -$12K 0.01% 235
2024
Q1 		$901K Sell
6,825
-249
-4% -$31.1K 0.02% 215
2023
Q4 		$861K Sell
7,074
-563
-7% -$62.8K 0.02% 217
2023
Q3 		$857K Buy
7,637
+1,046
+16% +$133K 0.02% 214
2023
Q2 		$960K Sell
6,591
-50
-0.8% -$6.79K 0.02% 201
2023
Q1 		$858K Sell
6,641
-6
-0.1% -$753 0.02% 202
2022
Q4 		$847K Buy
6,647
+119
+2% +$13.8K 0.02% 195
2022
Q3 		$683K Sell
6,528
-2
-0% -$219 0.02% 215
2022
Q2 		$686K Sell
6,530
-768
-11% -$91.1K 0.02% 223
2022
Q1 		$933K Buy
7,298
+14
+0.2% +$1.69K 0.02% 211
2021
Q4 		$898K Sell
7,284
-412
-5% -$53.9K 0.02% 223
2021
Q3 		$1.09M Buy
7,696
+182
+2% +$26.8K 0.03% 198
2021
Q2 		$1.17M Sell
7,514
-196
-3% -$31.7K 0.03% 199
2021
Q1 		$1.2M Buy
7,710
+198
+3% +$30.7K 0.03% 187
2020
Q4 		$1.12M Sell
7,512
-201
-3% -$28.4K 0.03% 196
2020
Q3 		$1.02M Sell
7,713
-108
-1% -$14.1K 0.03% 188
2020
Q2 		$906K Sell
7,821
-103
-1% -$11.9K 0.03% 191
2020
Q1 		$778K Buy
7,924
+180
+2% +$23.6K 0.03% 186
2019
Q4 		$1.13M Hold
7,744
– – 0.04% 190
2019
Q3 		$1.03M Sell
7,744
-28
-0.4% -$3.62K 0.04% 198
2019
Q2 		$888K Buy
+7,772
New +$910K 0.03% 210
2018
Q4 		– Sell
-4,224
Closed -$539K – 337
2018
Q3 		$539K Sell
4,224
-327
-7% -$38.9K 0.02% 222
2018
Q2 		$492K Buy
4,551
+59
+1% +$6.42K 0.02% 230
2018
Q1 		$476K Sell
4,492
-58
-1% -$6.74K 0.02% 232
2017
Q4 		$533K Buy
4,550
+327
+8% +$37K 0.02% 236
2017
Q3 		$480K Sell
4,223
-327
-7% -$37.7K 0.02% 231
2017
Q2 		$567K Hold
4,550
– – 0.03% 228
2017
Q1 		$540K Hold
4,550
– – 0.02% 221
2016
Q4 		$456K Hold
4,550
– – 0.02% 228
2016
Q3 		$574K Sell
4,550
-41
-0.9% -$5.07K 0.03% 214
2016
Q2 		$536K Hold
4,591
– – 0.03% 215
2016
Q1 		$475K Buy
4,591
+10
+0.2% +$967 0.02% 213
2015
Q4 		$456K Buy
4,581
+257
+6% +$25.1K 0.02% 223
2015
Q3 		$394K Hold
4,324
– – 0.02% 225
2015
Q2 		$458K Hold
4,324
– – 0.02% 220
2015
Q1 		$494K Sell
4,324
-587
-12% -$67K 0.02% 216
2014
Q4 		$541K Sell
4,911
-93
-2% -$9.8K 0.03% 221
2014
Q3 		$488K Buy
5,004
+1,102
+28% +$108K 0.03% 219
2014
Q2 		$394K Hold
3,902
– – 0.02% 229
2014
Q1 		$359K Sell
3,902
-103
-3% -$9.49K 0.02% 232
2013
Q4 		$362K Buy
4,005
+62
+2% +$5.37K 0.02% 229
2013
Q3 		$314K Hold
3,943
– – 0.02% 241
2013
Q2 		$287K Buy
+3,943
New +$295K 0.02% 241

Other funds holding ZBH

DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return
QAM
QSM Asset Management London, United Kingdom $193M AUM 47.49% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
GHAM
Gilman Hill Asset Management New Canaan, Connecticut $731M AUM 19.41% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

HM Payson & Co's ZBH Position: Q2 2026 in Review

HM Payson & Co held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 4,669 shares worth $402K. The position accounts for 0.01% of the portfolio, ranked #329.

HM Payson & Co first reported a position in ZBH in Q2 2013 and has held it in 51 quarters since. The position peaked at $1.2M in Q1 2021. 132 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • HM Payson & Co held 4,669 shares of Zimmer Biomet worth $402K as of Q2 2026.
  • HM Payson & Co left its Zimmer Biomet share count unchanged in Q2 2026.
  • Zimmer Biomet made up 0.01% of HM Payson & Co's portfolio in Q2 2026, its #329 holding.
  • HM Payson & Co first reported a position in Zimmer Biomet in Q2 2013 and has held it in 51 quarters since.
  • HM Payson & Co's Zimmer Biomet position peaked at $1.2M in Q1 2021.
  • 132 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on HM Payson & Co's 13F filing for Q2 2026, filed 17 Jul 2026.